Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP) is a Health Information Services company in the Healthcare sector listed on the NASDAQ.

As of Oct 7, 2026: market cap $374M; returns 1 week +0.4%, 1 year +12.1%.

Simulations Plus, Inc. (SLP) is a global leader in model-informed and AI-accelerated drug development, providing advanced software and consulting services to the biopharma industry. The company's offerings enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization.

Groups SLP belongs to

• Healthcare Technology
• Life Sciences Tools & Services
• Biotechnology
• Software
• Pharmaceuticals
• Application Software
• Drug Discovery
• Artificial Intelligence
• Life Sciences
• SaaS
• Healthcare IT
• Consulting
• Machine Learning
• Data Analytics

SLP financial model: income statement, cash flow and balance sheet